These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 17456726)

  • 1. Cellular mechanisms in sepsis.
    Jean-Baptiste E
    J Intensive Care Med; 2007; 22(2):63-72. PubMed ID: 17456726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sepsis and septic shock.
    Zanetti G; Baumgartner JD; Glauser MP
    Schweiz Med Wochenschr; 1997 Mar; 127(12):489-99. PubMed ID: 9106949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic agents in the treatment of severe sepsis.
    Iqbal O; Messmore H; Fareed J; Ahmad S; Hoppensteadt D; Hazar S; Tobu M; Aziz S; Wehrmacher W
    Expert Opin Emerg Drugs; 2002 May; 7(1):111-39. PubMed ID: 15989540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune dysfunction in murine polymicrobial sepsis: mediators, macrophages, lymphocytes and apoptosis.
    Ayala A; Chaudry IH
    Shock; 1996; 6 Suppl 1():S27-38. PubMed ID: 8828095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology and treatment of gram-negative sepsis.
    DiPiro JT
    Am J Hosp Pharm; 1990 Nov; 47(11 Suppl 3):S6-10. PubMed ID: 2275478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compartmentalization of the inflammatory response in sepsis and SIRS.
    Cavaillon JM; Annane D
    J Endotoxin Res; 2006; 12(3):151-70. PubMed ID: 16719987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caspase-3 activation, Bcl-2 contents, and soluble FAS-ligand are not related to the inflammatory marker profile in patients with sepsis and septic shock.
    Kriebel F; Wittemann S; Hsu HY; Joos T; Weiss M; Schneider EM
    Ann N Y Acad Sci; 2006 Dec; 1090():168-76. PubMed ID: 17384259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of genomic polymorphisms on the course of sepsis: is there a concept for gene therapy?
    Stüber F
    J Am Soc Nephrol; 2001 Feb; 12 Suppl 17():S60-4. PubMed ID: 11251034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-activating factor in septic shock.
    Koltai M; Hosford D; Braquet PG
    New Horiz; 1993 Feb; 1(1):87-95. PubMed ID: 7922397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular changes in association with defense mechanisms in intra-abdominal sepsis.
    Pavlidis TE
    Minerva Chir; 2003 Dec; 58(6):777-81. PubMed ID: 14663404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of bacterial-DNA in cirrhosis identifies a subgroup of patients with marked inflammatory response not related to endotoxin.
    González-Navajas JM; Bellot P; Francés R; Zapater P; Muñoz C; García-Pagán JC; Pascual S; Pérez-Mateo M; Bosch J; Such J
    J Hepatol; 2008 Jan; 48(1):61-7. PubMed ID: 17998145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular biology and immunopathogenetic mechanisms of sepsis].
    Průcha M
    Cas Lek Cesk; 2009; 148(2):86-90. PubMed ID: 19637444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mediators of septic shock: new approaches for interrupting the endogenous inflammatory cascade.
    Giroir BP
    Crit Care Med; 1993 May; 21(5):780-9. PubMed ID: 8482101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of monocyte human leukocyte antigen-DR in relation with sepsis severity and plasma mediators.
    Payen D; Faivre V; Lukaszewicz AC; Villa F; Goldberg P
    Minerva Anestesiol; 2009 Sep; 75(9):484-93. PubMed ID: 19644434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium: a regulator of the inflammatory response in endotoxemia and sepsis.
    Hotchkiss RS; Karl IE
    New Horiz; 1996 Feb; 4(1):58-71. PubMed ID: 8689276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipopolysaccharide binding protein in a surgical intensive care unit: a marker of sepsis?
    Sakr Y; Burgett U; Nacul FE; Reinhart K; Brunkhorst F
    Crit Care Med; 2008 Jul; 36(7):2014-22. PubMed ID: 18552695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokines and sepsis: pathophysiology and therapy.
    Shapiro L; Gelfand JA
    New Horiz; 1993 Feb; 1(1):13-22. PubMed ID: 7922386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional upregulation of inflammatory cytokines in human intestinal epithelial cells following Vibrio cholerae infection.
    Bandyopadhaya A; Sarkar M; Chaudhuri K
    FEBS J; 2007 Sep; 274(17):4631-42. PubMed ID: 17697117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune modulation and sepsis.
    Karzai W; Reinhart K
    Int J Clin Pract; 1997 Jun; 51(4):232-7. PubMed ID: 9287265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced glycation end products and lipopolysaccharide synergistically stimulate proinflammatory cytokine/chemokine production in endothelial cells via activation of both mitogen-activated protein kinases and nuclear factor-kappaB.
    Liu J; Zhao S; Tang J; Li Z; Zhong T; Liu Y; Chen D; Zhao M; Li Y; Gong X; Deng P; Wang JH; Jiang Y
    FEBS J; 2009 Aug; 276(16):4598-606. PubMed ID: 19645720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.